A thiochromenone antibiotic derived from the quinolone signal selectively targets the Gram-negative pathogen .

The quinolone signal (PQS) is an important quorum sensing signal of the pathogen . We discovered an additional activity of PQS as a narrow spectrum antibiotic. Exploiting the privileged structure of PQS by the synthesis of heteroatom-substituted analogues led to a class of 2-alkyl-3-hydroxythiochromen-4-ones with highly potent antibiotic activity against the nasopharyngeal pathogen . Synthetic optimization resulted in minimum inhibitory concentrations in the nanomolar range even for clinical isolates of . Surprisingly, the growth of other human pathogens and commensals, including closely related species, was not inhibited, indicating exceptional species selectivity. Mechanistic studies revealed that the antibiotic was bactericidal and likely inhibits a target in the primary energy metabolism causing rapid depletion of the cellular ATP pool.